TargetMol

Patchouli alcohol

Product Code:
 
TAR-T2916
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2916-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2916-25mg25mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Patchouli alcohol is a sesquiterpene alcohol found in patchouli oil. It has antibacterial, antifungal, and antiviral actions. Patchouli alcohol also suppresses inflammation induced by lipopolysaccharide in vivo. Topical application of patchouli alcohol accelerates recovery from ultraviolet irradiation-induced skin damage through antioxidant and anti-inflammatory effects.
CAS:
5986-55-0
Formula:
C15H26O
Molecular Weight:
222.37
Pathway:
Microbiology/Virology
Purity:
0.998
SMILES:
C[C@@]12[C@]3(O)C(C)(C)[C@@](C[C@]1([C@@H](C)CC3)[H])(CC2)[H]
Target:
Antibacterial; Antifungal

References

1. Yu JL, et al. J Surg Res. 2015 Apr;194(2):537-43. 2. Wu H, et al. Inhibitory effect and possible mechanism of action of patchouli alcohol against influenza A (H2N2) virus. Molecules. 2011 Aug 3;16(8):6489-501. 3. Feng XX, et al. Effects of topical application of patchouli alcohol on the UV-induced skin photoaging in mice. Eur J Pharm Sci. 2014 Oct 15;63:113-23. 4. Yu Y, Zhang Y, Wang S, et al. Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K/Akt and ERK/MAPK signaling pathways[J]. Virology Journal. 2019, 16(1): 1-16.